pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 11·1 min read
save

Supreme Court pauses restrictions, keeps abortion pill mifepristone available through pharmacies and mail

May 11, 2026·read at STAT ↗RegulatoryNeutral

The Supreme Court issued an order that maintains current access to the abortion medication mifepristone while it reviews a case challenging FDA prescribing rules.

The order, signed by Justice Samuel Alito, means women can continue to obtain the pill from pharmacies or by mail without needing an in-person doctor visit, and it blocks a lower-court ruling that would have limited such distribution.

The case originates from a Louisiana lawsuit seeking to roll back the FDA’s guidelines, arguing the rules conflict with the state’s abortion ban. The Court’s temporary decision comes as it weighs whether to allow the appealed restrictions to take effect.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Supreme Court temporarily extends women’s access to a widely used abortion pill”

read at STAT ↗
724 words · retrieved May 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
MIFEPRISTONE7misoprostol
topics
Approval2

related stories

  • Oct 8FDA says its safety review of abortion pill will continue into next yearSTAT
  • Sep 25Opinion: FDA commissioner nominee Heidi Overton is ignoring the science on abortion drugSTAT
  • May 15Opinion: Telehealth abortion with mifepristone continues, with backup plans still in placeSTAT
  • May 14Supreme Court preserves access to widely used abortion pill, while lawsuit plays outSTAT
  • May 8Former FDA leaders, pharma speak out on mifepristoneSTAT